Loading…

Angiotensin-[1-12] interacts with angiotensin type I receptors

Angiotensin-(1–12) [Ang-(1–12)], a newer member of angiotensin peptides, is proposed to be converted enzymatically to angiotensin I (Ang I) and to angiotensin II (Ang II); the latter being the bioactive peptide. We studied the Ang-(1–12) and Ang II responses in COS-7 cells or CHO cells transfected w...

Full description

Saved in:
Bibliographic Details
Published in:Neuropharmacology 2014-06, Vol.81, p.267-273
Main Authors: Chan, King H., Chen, Yi H., Zhang, Ying, Wong, Yung H., Dun, Nae J.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c512t-261d3c38dc31f2bd7311992855a61bad0247a6a2388069c4bc1161cd47f1ae093
cites cdi_FETCH-LOGICAL-c512t-261d3c38dc31f2bd7311992855a61bad0247a6a2388069c4bc1161cd47f1ae093
container_end_page 273
container_issue
container_start_page 267
container_title Neuropharmacology
container_volume 81
creator Chan, King H.
Chen, Yi H.
Zhang, Ying
Wong, Yung H.
Dun, Nae J.
description Angiotensin-(1–12) [Ang-(1–12)], a newer member of angiotensin peptides, is proposed to be converted enzymatically to angiotensin I (Ang I) and to angiotensin II (Ang II); the latter being the bioactive peptide. We studied the Ang-(1–12) and Ang II responses in COS-7 cells or CHO cells transfected with 5 μg AT1R by monitoring [Ca2+]i using the Fluo-4. Ang II (1 pM–1 μM) and Ang-(1–12) (5 pM–5 μM) increased [Ca2+]i with an EC50 of 0.19 nM and 24 nM in COS-7 cells; and 0.65 nM and 28.7 nM in CHO cells. The AT1R antagonist losartan (1 nM–10 μM) suppressed [Ca2+]i induced by Ang-(1–12) and Ang II. In CHO cells transfected with 5 μg AT2R, Ang II (1 pM-1 μM) increased [Ca2+]i, with an EC50 of 9.68 nM; whereas, Ang-(1–12) (5 pM–5 μM) failed to elicit a significant change in [Ca2+]i. In CHO cells transfected with AT1R, Ang-(1–12) stimulated ERK phosphorylation with a potency 300-fold less than that of Ang II. To evaluate the activity of Ang-(1–12) on native AT1R, whole cell patch recordings were made from neurons in the rat hypothalamic slices. Ang II or Ang-(1–12) ejected by pressure from a micropipette elicited a membrane depolarization; the latter was blocked by losartan (10 μM), and not affected by the AT2R antagonist PD123319 (10 μM), nor by the angiotensin converting enzyme inhibitor captopril (10 μM). Our result shows that Ang-(1–12) may produce its biological activity by acting directly on AT1R, albeit at a concentration higher than that of Ang II. •Ang-(1–12) or Ang II mobilizes Ca2+ in cell lines transfected with AT1R cDNA.•Ang-(1–12) or Ang II induces ERK phosphorylation in cell lines.•Ang-(1–12) or Ang II depolarize neurons in rat hypothalamic slices.•Ang-(1–12) depolarization is suppressed by losartan and not affected by captopril.•Ang-(1-12) may directly act on AT1R, in addition to being a precursor to the formation of Ang I and Ang II.
doi_str_mv 10.1016/j.neuropharm.2013.06.022
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3823637</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0028390813002906</els_id><sourcerecordid>1534848349</sourcerecordid><originalsourceid>FETCH-LOGICAL-c512t-261d3c38dc31f2bd7311992855a61bad0247a6a2388069c4bc1161cd47f1ae093</originalsourceid><addsrcrecordid>eNqFkE1PGzEQhi1URELav1DtsZfdztgbr_cSKUWFIiFxgRNCluOdEEeJvbUdEP--G4WvnjjNYd6PmYexAqFCQPlzXXnaxdCvTNxWHFBUICvg_IiNUTWibEDWX9gYgKtStKBG7DSlNQDUCtUJG3GhuGibdsxmc__gQiafnC_vsER-XzifKRqbU_Hk8qow74oiP_dUXBaRLPU5xPSVHS_NJtG3lzlht-e_b87-lFfXF5dn86vSTpHnkkvshBWqswKXfNE1ArFtuZpOjcSF6YDXjZFmOEuBbG29sIgSbVc3SzQErZiw2SG33y221FnyOZqN7qPbmvisg3H6_413K_0QHvX-USmaIeDHS0AMf3eUst66ZGmzMZ7CLmmcilrVStT7LnWQ2hhSirR8q0HQe_x6rd_x6z1-DVIP-Afr949nvhlfeQ-CXwcBDbAeHUWdrCNvqXMD06y74D5v-QdYg5wh</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1534848349</pqid></control><display><type>article</type><title>Angiotensin-[1-12] interacts with angiotensin type I receptors</title><source>ScienceDirect Freedom Collection</source><creator>Chan, King H. ; Chen, Yi H. ; Zhang, Ying ; Wong, Yung H. ; Dun, Nae J.</creator><creatorcontrib>Chan, King H. ; Chen, Yi H. ; Zhang, Ying ; Wong, Yung H. ; Dun, Nae J.</creatorcontrib><description>Angiotensin-(1–12) [Ang-(1–12)], a newer member of angiotensin peptides, is proposed to be converted enzymatically to angiotensin I (Ang I) and to angiotensin II (Ang II); the latter being the bioactive peptide. We studied the Ang-(1–12) and Ang II responses in COS-7 cells or CHO cells transfected with 5 μg AT1R by monitoring [Ca2+]i using the Fluo-4. Ang II (1 pM–1 μM) and Ang-(1–12) (5 pM–5 μM) increased [Ca2+]i with an EC50 of 0.19 nM and 24 nM in COS-7 cells; and 0.65 nM and 28.7 nM in CHO cells. The AT1R antagonist losartan (1 nM–10 μM) suppressed [Ca2+]i induced by Ang-(1–12) and Ang II. In CHO cells transfected with 5 μg AT2R, Ang II (1 pM-1 μM) increased [Ca2+]i, with an EC50 of 9.68 nM; whereas, Ang-(1–12) (5 pM–5 μM) failed to elicit a significant change in [Ca2+]i. In CHO cells transfected with AT1R, Ang-(1–12) stimulated ERK phosphorylation with a potency 300-fold less than that of Ang II. To evaluate the activity of Ang-(1–12) on native AT1R, whole cell patch recordings were made from neurons in the rat hypothalamic slices. Ang II or Ang-(1–12) ejected by pressure from a micropipette elicited a membrane depolarization; the latter was blocked by losartan (10 μM), and not affected by the AT2R antagonist PD123319 (10 μM), nor by the angiotensin converting enzyme inhibitor captopril (10 μM). Our result shows that Ang-(1–12) may produce its biological activity by acting directly on AT1R, albeit at a concentration higher than that of Ang II. •Ang-(1–12) or Ang II mobilizes Ca2+ in cell lines transfected with AT1R cDNA.•Ang-(1–12) or Ang II induces ERK phosphorylation in cell lines.•Ang-(1–12) or Ang II depolarize neurons in rat hypothalamic slices.•Ang-(1–12) depolarization is suppressed by losartan and not affected by captopril.•Ang-(1-12) may directly act on AT1R, in addition to being a precursor to the formation of Ang I and Ang II.</description><identifier>ISSN: 0028-3908</identifier><identifier>EISSN: 1873-7064</identifier><identifier>DOI: 10.1016/j.neuropharm.2013.06.022</identifier><identifier>PMID: 23823979</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>ACE inhibitor ; Angiotensin I - pharmacology ; Angiotensin II ; Angiotensin II - pharmacology ; Angiotensinogen - pharmacology ; Animals ; Animals, Newborn ; CHO Cells ; Cricetulus ; Dose-Response Relationship, Drug ; Extracellular Signal-Regulated MAP Kinases - metabolism ; Female ; G-protein ; Gene Expression Regulation - drug effects ; Hypothalamus ; Male ; Membrane Potentials - drug effects ; Peptide Fragments - pharmacology ; Phosphorylation - drug effects ; Protein Binding - drug effects ; Rats ; Rats, Sprague-Dawley ; Receptor, Angiotensin, Type 1 - genetics ; Receptor, Angiotensin, Type 1 - metabolism ; Transfection</subject><ispartof>Neuropharmacology, 2014-06, Vol.81, p.267-273</ispartof><rights>2013 Elsevier Ltd</rights><rights>Copyright © 2013 Elsevier Ltd. All rights reserved.</rights><rights>2013 Elsevier Ltd. All rights reserved 2013</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c512t-261d3c38dc31f2bd7311992855a61bad0247a6a2388069c4bc1161cd47f1ae093</citedby><cites>FETCH-LOGICAL-c512t-261d3c38dc31f2bd7311992855a61bad0247a6a2388069c4bc1161cd47f1ae093</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,778,782,883,27907,27908</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23823979$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chan, King H.</creatorcontrib><creatorcontrib>Chen, Yi H.</creatorcontrib><creatorcontrib>Zhang, Ying</creatorcontrib><creatorcontrib>Wong, Yung H.</creatorcontrib><creatorcontrib>Dun, Nae J.</creatorcontrib><title>Angiotensin-[1-12] interacts with angiotensin type I receptors</title><title>Neuropharmacology</title><addtitle>Neuropharmacology</addtitle><description>Angiotensin-(1–12) [Ang-(1–12)], a newer member of angiotensin peptides, is proposed to be converted enzymatically to angiotensin I (Ang I) and to angiotensin II (Ang II); the latter being the bioactive peptide. We studied the Ang-(1–12) and Ang II responses in COS-7 cells or CHO cells transfected with 5 μg AT1R by monitoring [Ca2+]i using the Fluo-4. Ang II (1 pM–1 μM) and Ang-(1–12) (5 pM–5 μM) increased [Ca2+]i with an EC50 of 0.19 nM and 24 nM in COS-7 cells; and 0.65 nM and 28.7 nM in CHO cells. The AT1R antagonist losartan (1 nM–10 μM) suppressed [Ca2+]i induced by Ang-(1–12) and Ang II. In CHO cells transfected with 5 μg AT2R, Ang II (1 pM-1 μM) increased [Ca2+]i, with an EC50 of 9.68 nM; whereas, Ang-(1–12) (5 pM–5 μM) failed to elicit a significant change in [Ca2+]i. In CHO cells transfected with AT1R, Ang-(1–12) stimulated ERK phosphorylation with a potency 300-fold less than that of Ang II. To evaluate the activity of Ang-(1–12) on native AT1R, whole cell patch recordings were made from neurons in the rat hypothalamic slices. Ang II or Ang-(1–12) ejected by pressure from a micropipette elicited a membrane depolarization; the latter was blocked by losartan (10 μM), and not affected by the AT2R antagonist PD123319 (10 μM), nor by the angiotensin converting enzyme inhibitor captopril (10 μM). Our result shows that Ang-(1–12) may produce its biological activity by acting directly on AT1R, albeit at a concentration higher than that of Ang II. •Ang-(1–12) or Ang II mobilizes Ca2+ in cell lines transfected with AT1R cDNA.•Ang-(1–12) or Ang II induces ERK phosphorylation in cell lines.•Ang-(1–12) or Ang II depolarize neurons in rat hypothalamic slices.•Ang-(1–12) depolarization is suppressed by losartan and not affected by captopril.•Ang-(1-12) may directly act on AT1R, in addition to being a precursor to the formation of Ang I and Ang II.</description><subject>ACE inhibitor</subject><subject>Angiotensin I - pharmacology</subject><subject>Angiotensin II</subject><subject>Angiotensin II - pharmacology</subject><subject>Angiotensinogen - pharmacology</subject><subject>Animals</subject><subject>Animals, Newborn</subject><subject>CHO Cells</subject><subject>Cricetulus</subject><subject>Dose-Response Relationship, Drug</subject><subject>Extracellular Signal-Regulated MAP Kinases - metabolism</subject><subject>Female</subject><subject>G-protein</subject><subject>Gene Expression Regulation - drug effects</subject><subject>Hypothalamus</subject><subject>Male</subject><subject>Membrane Potentials - drug effects</subject><subject>Peptide Fragments - pharmacology</subject><subject>Phosphorylation - drug effects</subject><subject>Protein Binding - drug effects</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Receptor, Angiotensin, Type 1 - genetics</subject><subject>Receptor, Angiotensin, Type 1 - metabolism</subject><subject>Transfection</subject><issn>0028-3908</issn><issn>1873-7064</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNqFkE1PGzEQhi1URELav1DtsZfdztgbr_cSKUWFIiFxgRNCluOdEEeJvbUdEP--G4WvnjjNYd6PmYexAqFCQPlzXXnaxdCvTNxWHFBUICvg_IiNUTWibEDWX9gYgKtStKBG7DSlNQDUCtUJG3GhuGibdsxmc__gQiafnC_vsER-XzifKRqbU_Hk8qow74oiP_dUXBaRLPU5xPSVHS_NJtG3lzlht-e_b87-lFfXF5dn86vSTpHnkkvshBWqswKXfNE1ArFtuZpOjcSF6YDXjZFmOEuBbG29sIgSbVc3SzQErZiw2SG33y221FnyOZqN7qPbmvisg3H6_413K_0QHvX-USmaIeDHS0AMf3eUst66ZGmzMZ7CLmmcilrVStT7LnWQ2hhSirR8q0HQe_x6rd_x6z1-DVIP-Afr949nvhlfeQ-CXwcBDbAeHUWdrCNvqXMD06y74D5v-QdYg5wh</recordid><startdate>20140601</startdate><enddate>20140601</enddate><creator>Chan, King H.</creator><creator>Chen, Yi H.</creator><creator>Zhang, Ying</creator><creator>Wong, Yung H.</creator><creator>Dun, Nae J.</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>5PM</scope></search><sort><creationdate>20140601</creationdate><title>Angiotensin-[1-12] interacts with angiotensin type I receptors</title><author>Chan, King H. ; Chen, Yi H. ; Zhang, Ying ; Wong, Yung H. ; Dun, Nae J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c512t-261d3c38dc31f2bd7311992855a61bad0247a6a2388069c4bc1161cd47f1ae093</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>ACE inhibitor</topic><topic>Angiotensin I - pharmacology</topic><topic>Angiotensin II</topic><topic>Angiotensin II - pharmacology</topic><topic>Angiotensinogen - pharmacology</topic><topic>Animals</topic><topic>Animals, Newborn</topic><topic>CHO Cells</topic><topic>Cricetulus</topic><topic>Dose-Response Relationship, Drug</topic><topic>Extracellular Signal-Regulated MAP Kinases - metabolism</topic><topic>Female</topic><topic>G-protein</topic><topic>Gene Expression Regulation - drug effects</topic><topic>Hypothalamus</topic><topic>Male</topic><topic>Membrane Potentials - drug effects</topic><topic>Peptide Fragments - pharmacology</topic><topic>Phosphorylation - drug effects</topic><topic>Protein Binding - drug effects</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Receptor, Angiotensin, Type 1 - genetics</topic><topic>Receptor, Angiotensin, Type 1 - metabolism</topic><topic>Transfection</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chan, King H.</creatorcontrib><creatorcontrib>Chen, Yi H.</creatorcontrib><creatorcontrib>Zhang, Ying</creatorcontrib><creatorcontrib>Wong, Yung H.</creatorcontrib><creatorcontrib>Dun, Nae J.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Neuropharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chan, King H.</au><au>Chen, Yi H.</au><au>Zhang, Ying</au><au>Wong, Yung H.</au><au>Dun, Nae J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Angiotensin-[1-12] interacts with angiotensin type I receptors</atitle><jtitle>Neuropharmacology</jtitle><addtitle>Neuropharmacology</addtitle><date>2014-06-01</date><risdate>2014</risdate><volume>81</volume><spage>267</spage><epage>273</epage><pages>267-273</pages><issn>0028-3908</issn><eissn>1873-7064</eissn><abstract>Angiotensin-(1–12) [Ang-(1–12)], a newer member of angiotensin peptides, is proposed to be converted enzymatically to angiotensin I (Ang I) and to angiotensin II (Ang II); the latter being the bioactive peptide. We studied the Ang-(1–12) and Ang II responses in COS-7 cells or CHO cells transfected with 5 μg AT1R by monitoring [Ca2+]i using the Fluo-4. Ang II (1 pM–1 μM) and Ang-(1–12) (5 pM–5 μM) increased [Ca2+]i with an EC50 of 0.19 nM and 24 nM in COS-7 cells; and 0.65 nM and 28.7 nM in CHO cells. The AT1R antagonist losartan (1 nM–10 μM) suppressed [Ca2+]i induced by Ang-(1–12) and Ang II. In CHO cells transfected with 5 μg AT2R, Ang II (1 pM-1 μM) increased [Ca2+]i, with an EC50 of 9.68 nM; whereas, Ang-(1–12) (5 pM–5 μM) failed to elicit a significant change in [Ca2+]i. In CHO cells transfected with AT1R, Ang-(1–12) stimulated ERK phosphorylation with a potency 300-fold less than that of Ang II. To evaluate the activity of Ang-(1–12) on native AT1R, whole cell patch recordings were made from neurons in the rat hypothalamic slices. Ang II or Ang-(1–12) ejected by pressure from a micropipette elicited a membrane depolarization; the latter was blocked by losartan (10 μM), and not affected by the AT2R antagonist PD123319 (10 μM), nor by the angiotensin converting enzyme inhibitor captopril (10 μM). Our result shows that Ang-(1–12) may produce its biological activity by acting directly on AT1R, albeit at a concentration higher than that of Ang II. •Ang-(1–12) or Ang II mobilizes Ca2+ in cell lines transfected with AT1R cDNA.•Ang-(1–12) or Ang II induces ERK phosphorylation in cell lines.•Ang-(1–12) or Ang II depolarize neurons in rat hypothalamic slices.•Ang-(1–12) depolarization is suppressed by losartan and not affected by captopril.•Ang-(1-12) may directly act on AT1R, in addition to being a precursor to the formation of Ang I and Ang II.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>23823979</pmid><doi>10.1016/j.neuropharm.2013.06.022</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0028-3908
ispartof Neuropharmacology, 2014-06, Vol.81, p.267-273
issn 0028-3908
1873-7064
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3823637
source ScienceDirect Freedom Collection
subjects ACE inhibitor
Angiotensin I - pharmacology
Angiotensin II
Angiotensin II - pharmacology
Angiotensinogen - pharmacology
Animals
Animals, Newborn
CHO Cells
Cricetulus
Dose-Response Relationship, Drug
Extracellular Signal-Regulated MAP Kinases - metabolism
Female
G-protein
Gene Expression Regulation - drug effects
Hypothalamus
Male
Membrane Potentials - drug effects
Peptide Fragments - pharmacology
Phosphorylation - drug effects
Protein Binding - drug effects
Rats
Rats, Sprague-Dawley
Receptor, Angiotensin, Type 1 - genetics
Receptor, Angiotensin, Type 1 - metabolism
Transfection
title Angiotensin-[1-12] interacts with angiotensin type I receptors
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T01%3A05%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Angiotensin-%5B1-12%5D%20interacts%20with%20angiotensin%20type%20I%20receptors&rft.jtitle=Neuropharmacology&rft.au=Chan,%20King%20H.&rft.date=2014-06-01&rft.volume=81&rft.spage=267&rft.epage=273&rft.pages=267-273&rft.issn=0028-3908&rft.eissn=1873-7064&rft_id=info:doi/10.1016/j.neuropharm.2013.06.022&rft_dat=%3Cproquest_pubme%3E1534848349%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c512t-261d3c38dc31f2bd7311992855a61bad0247a6a2388069c4bc1161cd47f1ae093%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1534848349&rft_id=info:pmid/23823979&rfr_iscdi=true